Anti-androgenic therapy with finasteride improves cardiac function, attenuates remodeling and reverts pathologic gene-expression after myocardial infarction in mice

Maladaptive cardiac remodeling after myocardial infarction (MI) is increasingly contributing to the prevalence of chronic heart failure. Women show less severe remodeling, a reduced mortality and a better systolic function after MI compared to men. Although sex hormones are being made responsible fo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Froese, Natali (VerfasserIn) , Heineke, Jörg (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 14 August 2018
In: Journal of molecular and cellular cardiology
Year: 2018, Jahrgang: 122, Pages: 114-124
ISSN:1095-8584
DOI:10.1016/j.yjmcc.2018.08.011
Online-Zugang:Verlag, Volltext: https://doi.org/10.1016/j.yjmcc.2018.08.011
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0022282818307934
Volltext
Verfasserangaben:Natali Froese, Honghui Wang, Carolin Zwadlo, Yong Wang, Andrea Grund, Anna Gigina, Melanie Hofmann, Katja Kilian, Gesine Scharf, Mortimer Korf-Klingebiel, Anna Melchert, Maria Elena Ricci Signorini, Caroline Halloin, Robert Zweigerdt, Ulrich Martin, Ina Gruh, Kai C. Wollert, Robert Geffers, Johann Bauersachs, Joerg Heineke

MARC

LEADER 00000caa a2200000 c 4500
001 1676959025
003 DE-627
005 20230428155109.0
007 cr uuu---uuuuu
008 190913s2018 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.yjmcc.2018.08.011  |2 doi 
035 |a (DE-627)1676959025 
035 |a (DE-599)KXP1676959025 
035 |a (OCoLC)1341243439 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Froese, Natali  |e VerfasserIn  |0 (DE-588)1194693830  |0 (DE-627)1676958525  |4 aut 
245 1 0 |a Anti-androgenic therapy with finasteride improves cardiac function, attenuates remodeling and reverts pathologic gene-expression after myocardial infarction in mice  |c Natali Froese, Honghui Wang, Carolin Zwadlo, Yong Wang, Andrea Grund, Anna Gigina, Melanie Hofmann, Katja Kilian, Gesine Scharf, Mortimer Korf-Klingebiel, Anna Melchert, Maria Elena Ricci Signorini, Caroline Halloin, Robert Zweigerdt, Ulrich Martin, Ina Gruh, Kai C. Wollert, Robert Geffers, Johann Bauersachs, Joerg Heineke 
264 1 |c 14 August 2018 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 13.09.2019 
520 |a Maladaptive cardiac remodeling after myocardial infarction (MI) is increasingly contributing to the prevalence of chronic heart failure. Women show less severe remodeling, a reduced mortality and a better systolic function after MI compared to men. Although sex hormones are being made responsible for these differences, it remains currently unknown how this could be translated into therapeutic strategies. Because we had recently demonstrated that inhibition of the conversion of testosterone to its highly active metabolite dihydrotestosterone (DHT) by finasteride effectively reduces cardiac hypertrophy and improves heart function during pressure overload, we asked here whether this strategy could be applied to post-MI remodeling. We found increased abundance of DHT and increased expression of androgen responsive genes in the mouse myocardium after experimental MI. Treatment of mice with finasteride for 21days (starting 7days after surgery), reduced myocardial DHT levels and markedly attenuated cardiac dysfunction as well as hypertrophic remodeling after MI. Histological and molecular analyses showed reduced MI triggered interstitial fibrosis, reduced cardiomyocyte hypertrophy and increased capillary density in the myocardium of finasteride treated mice. Mechanistically, this was associated with decreased activation of myocardial growth-signaling pathways, a comprehensive normalization of pathological myocardial gene-expression as revealed by RNA deep-sequencing and with direct effects of finasteride on cardiac fibroblasts and endothelial cells. In conclusion, we demonstrated a beneficial role of anti-androgenic treatment with finasteride in post-MI remodeling of mice. As finasteride is already approved for the treatment of benign prostate disease, it could potentially be evaluated as therapeutic strategy for heart failure after MI. 
650 4 |a Cardiac hypertrophy 
650 4 |a Myocardial remodeling 
650 4 |a Signaling 
650 4 |a Testosterone 
700 1 |a Heineke, Jörg  |d 1974-  |e VerfasserIn  |0 (DE-588)122672321  |0 (DE-627)082082715  |0 (DE-576)293374805  |4 aut 
773 0 8 |i Enthalten in  |t Journal of molecular and cellular cardiology  |d New York, NY [u.a.] : Elsevier, 1970  |g 122(2018), Seite 114-124  |h Online-Ressource  |w (DE-627)267328095  |w (DE-600)1469767-1  |w (DE-576)104193913  |x 1095-8584  |7 nnas  |a Anti-androgenic therapy with finasteride improves cardiac function, attenuates remodeling and reverts pathologic gene-expression after myocardial infarction in mice 
773 1 8 |g volume:122  |g year:2018  |g pages:114-124  |g extent:11  |a Anti-androgenic therapy with finasteride improves cardiac function, attenuates remodeling and reverts pathologic gene-expression after myocardial infarction in mice 
856 4 0 |u https://doi.org/10.1016/j.yjmcc.2018.08.011  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0022282818307934  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20190913 
993 |a Article 
994 |a 2018 
998 |g 122672321  |a Heineke, Jörg  |m 122672321:Heineke, Jörg  |d 60000  |e 60000PH122672321  |k 0/60000/  |p 20  |y j 
999 |a KXP-PPN1676959025  |e 3515843051 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"title":[{"title":"Anti-androgenic therapy with finasteride improves cardiac function, attenuates remodeling and reverts pathologic gene-expression after myocardial infarction in mice","title_sort":"Anti-androgenic therapy with finasteride improves cardiac function, attenuates remodeling and reverts pathologic gene-expression after myocardial infarction in mice"}],"relHost":[{"origin":[{"publisherPlace":"New York, NY [u.a.] ; London","dateIssuedKey":"1970","dateIssuedDisp":"1970-","publisher":"Elsevier ; Academic Press"}],"recId":"267328095","type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Anti-androgenic therapy with finasteride improves cardiac function, attenuates remodeling and reverts pathologic gene-expression after myocardial infarction in miceJournal of molecular and cellular cardiology","physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1095-8584"],"zdb":["1469767-1"],"eki":["267328095"]},"note":["Gesehen am 21.01.20","Ungezählte Beil.: Supplement"],"corporate":[{"role":"isb","display":"International Society for Heart Research"}],"name":{"displayForm":["International Society for Heart Research"]},"pubHistory":["1.1970 -"],"title":[{"title_sort":"Journal of molecular and cellular cardiology","title":"Journal of molecular and cellular cardiology"}],"language":["eng"],"part":{"volume":"122","year":"2018","text":"122(2018), Seite 114-124","pages":"114-124","extent":"11"}}],"note":["Gesehen am 13.09.2019"],"physDesc":[{"extent":"11 S."}],"id":{"eki":["1676959025"],"doi":["10.1016/j.yjmcc.2018.08.011"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"14 August 2018","dateIssuedKey":"2018"}],"recId":"1676959025","person":[{"family":"Froese","display":"Froese, Natali","role":"aut","given":"Natali"},{"display":"Heineke, Jörg","given":"Jörg","role":"aut","family":"Heineke"}],"name":{"displayForm":["Natali Froese, Honghui Wang, Carolin Zwadlo, Yong Wang, Andrea Grund, Anna Gigina, Melanie Hofmann, Katja Kilian, Gesine Scharf, Mortimer Korf-Klingebiel, Anna Melchert, Maria Elena Ricci Signorini, Caroline Halloin, Robert Zweigerdt, Ulrich Martin, Ina Gruh, Kai C. Wollert, Robert Geffers, Johann Bauersachs, Joerg Heineke"]}} 
SRT |a FROESENATAANTIANDROG1420